Scott Primack
Physical Medicine & Rehabilitation · Greenwood Village, CONPI 1386609428
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $465 and has fallen 81.2% since, to $87 in 2025.
Across 38 payments — averaging $34.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$207
- Boston Scientific$197
- SPR Therapeutics, Inc$177
- International Rehabilitative Sciences, Inc$97
- Avanos Medical$87
- Nevro Corp.$51
- plus $496 from 21 others
What the payments were for
- Food & beverage$1,311100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 1 | $207 |
| Boston Scientific | 2 | $197 |
| SPR Therapeutics, Inc | 3 | $177 |
| International Rehabilitative Sciences, Inc | 1 | $97 |
| Avanos Medical | 1 | $87 |
| Nevro Corp. | 2 | $51 |
| Scilex Pharmaceuticals Inc. | 3 | $47 |
| AbbVie(2 entities) | 2 | $46 |
| Pfizer | 2 | $38 |
| Vertex | 2 | $34 |
| Novartis | 2 | $28 |
| Globus Medical | 1 | $28 |
| Biogen | 2 | $26 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Ossur Americas, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Amgen | 1 | $17 |
| Shionogi Inc | 1 | $16 |
| Fidia Pharma USA Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Stimwave Technologies Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,311 in reported general payments places this provider in the 80th percentile of 199 physical medicine & rehabilitation providers in Colorado.
See all physical medicine & rehabilitation providers in Colorado →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 24 | $76,984 |
| Hydromorphone Hcl | 33 | $1,453 |
| Oxycodone Hcl | 28 | $1,022 |
| Fentanyl | 16 | $913 |
| Morphine Sulfate ErMorphine Sulfate | 17 | $678 |
| Morphine Sulfate | 12 | $383 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $268 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $215 |
| Diazepam | 24 | $189 |
| Pregabalin | 19 | $179 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $96 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 15 | $94 |
| Tramadol Hcl | 15 | $43 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Greenwood Village
- Drew TrainorGreenwood Village$320K
- Joseph FillmoreGreenwood Village$3K
- William ScelzaEnglewood$16K
- Aakash ThakralGreeley$14K
- Alan WeintraubEnglewood$10K
- Ryan FlowersGreeley$10K
- Kristina BarberParker$9K
- Gin-Ming HsuDenver$8K
- Esther YoonLittleton$7K
- Cliff GronsethBoulder$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.